Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7301 USD | +1.40% | +2.58% | +6.12% |
2023 | NGM Biopharmaceuticals Says Phase 2b Trial of Potential Cirrhosis Treatment Meets Primary Endpoint | MT |
2023 | Alpine 4 Holdings, Inc.(NasdaqCM:ALPP) dropped from S&P Global BMI Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+6.12% | 19.45M | |
+11.65% | 110B | |
-2.36% | 28.8B | |
+15.90% | 22.19B | |
-12.89% | 18.27B | |
-7.70% | 17.5B | |
+15.78% | 15.92B | |
-5.50% | 11.75B | |
-1.88% | 10.61B | |
-4.52% | 9.65B |
- Stock Market
- Equities
- ALPP Stock
- News Alpine 4 Holdings, Inc.
- Alpine 4 Unit Signs Deal to Supply Unmanned Aerial Vehicles to US Government Contractor; Shares Rise